Pei Liu

ORCID: 0000-0003-2664-0551 · 3 papers in corpus · active 2013-2024

Study types

  • article 2
  • rct 1

Condition tags

  • endometriosis 2
  • dysmenorrhea 1
rct 2024
P2X3 Receptor Antagonist Eliapixant in Phase I Clinical Trials: Safety and Inter-ethnic Comparison of Pharmacokinetics in Healthy Chinese and Japanese Participants
Clinical pharmacokinetics ·doi:10.1007/s40262-024-01387-y

BACKGROUND: Afferent neuronal hypersensitization via P2X3 receptor signaling has been implicated as a driver of several disorders, including refractory chronic cough, endometriosis, diabetic neuropathic pain, and overactive bladder. Eliapix…

article 2021
17β-estradiol promotes angiogenesis through non-genomic activation of Smad1 signaling in endometriosis
Vascular pharmacology ·doi:10.1016/j.vph.2021.106932
article 2013
Altered Cytokine Gene Expression in Peripheral Blood Monocytes across the Menstrual Cycle in Primary Dysmenorrhea: A Case-Control Study
·doi:10.1371/journal.pone.0055200

Primary dysmenorrhea is one of the most common gynecological complaints in young women, but potential peripheral immunologic features underlying this condition remain undefined. In this paper, we compared 84 common cytokine gene expression …